Lilly expected to pay record sum in Zyprexa case

In a case brought by the U.S. Attorney's Office in Philadelphia, drug company Eli Lilly & Co. is expected to agree tomorrow to pay a record $1.4 billion to settle allegations that it illegally marketed its best-selling antipsychotic drug, Zyprexa, to patients who did not need it.

Copyright PHILY -
Contact Us